அடித்தளம் க்கு பிரதேற் வில்லி ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: Jun 18, 2021 RESEARCH TRIANGLE PARK, N.C., June 18, 2021 (GLOBE NEWSWIRE) G1 Therapeutics Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the appointment of Alicia Secor to its Board of Directors. With more than 30 years of experience in the life sciences industry, she has a proven track record of leading life sciences businesses, guiding products from clinical development through approval and global commercialization, and enabling companies to optimize the potential of innovative brands. Ms. Secor currently serves as President and Chief Executive Officer of Atalanta Therapeutics, Inc., a privately held biotechnology company pioneering new treatment options for neurodegenerative diseases and is a member of its Board of Directors.

United statesAlicia secorJack baileyFoundation for prader willi researchJazz pharmaceuticalsAtalanta therapeutics incGw pharmaceuticalsExchange commissionJuniper pharmaceuticals incHealth administrationTherapeutics incCatalent incNortheastern universityCorporate communicationsResearch triangle parkUniversity of new hampshire